Trial · NCT02970162
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | atrial fibrillation | Cardiac disorders | Amifampridine Phosphate | 0 | 13 | |
| other | atrial fibrillation | Cardiac disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | myocardial ischemia | Cardiac disorders | Amifampridine Phosphate | 0 | 13 | |
| other | myocardial ischemia | Cardiac disorders | Placebo (for Amifampridine Phosphate) | 4 | 13 | |
| other | motion sickness | Ear and labyrinth disorders | Amifampridine Phosphate | 0 | 13 | |
| other | motion sickness | Ear and labyrinth disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | diplopia | Eye disorders | Amifampridine Phosphate | 0 | 13 | |
| other | diplopia | Eye disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | eyelid ptosis | Eye disorders | Amifampridine Phosphate | 0 | 13 | |
| other | eyelid ptosis | Eye disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | dry mouth | Gastrointestinal disorders | Amifampridine Phosphate | 0 | 13 | |
| other | dry mouth | Gastrointestinal disorders | Placebo (for Amifampridine Phosphate) | 2 | 13 | |
| other | diarrhoea | Gastrointestinal disorders | Amifampridine Phosphate | 0 | 13 | |
| other | diarrhoea | Gastrointestinal disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | dysphagia | Gastrointestinal disorders | Amifampridine Phosphate | 0 | 13 | |
| other | dysphagia | Gastrointestinal disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | hypoaesthesia, oral | Gastrointestinal disorders | Amifampridine Phosphate | 0 | 13 | |
| other | hypoaesthesia, oral | Gastrointestinal disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 | |
| other | impaired gastric emptying | Gastrointestinal disorders | Amifampridine Phosphate | 0 | 13 | |
| other | impaired gastric emptying | Gastrointestinal disorders | Placebo (for Amifampridine Phosphate) | 1 | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02970162/events